The National Comprehensive Cancer Network® (NCCN®)--a non-profit alliance of leading cancer centers--brought together more ...

Patients with advanced kidney cancer, or renal cell carcinoma, have several new treatment paths to consider following the ...

Recent updates to the National Comprehensive Cancer Network (NCCN) guidelines for cutaneous squamous cell carcinoma (CSCC) ...

The 2026 NCCN Bladder Cancer Guidelines incorporate the IBCG five-factor model, introducing standardized risk stratification for intermediate-risk NMIBC.

The NCCN has updated its guidelines on breast, pancreatic, colon, rectal, non-small cell lung, and other cancers. The National Comprehensive Cancer Network (NCCN) has updated its treatment guidelines ...

ImmunityBio (IBRX) added ~7% in the premarket on Wednesday after the company announced that the National Comprehensive Cancer Network has updated its treatment guidelines to include an expanded use of ...

PLYMOUTH MEETING, PA [October 6, 2025] — Today, the National Comprehensive Cancer Network ® (NCCN ®)—a nonprofit responsible for globally utilized guidelines for cancer care—is sharing new NCCN ...

PLYMOUTH MEETING, PA [February 17, 2026] — The National Comprehensive Cancer Network ® (NCCN ®) today published new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) for Pediatric Soft ...

ImmunityBio Inc. (NASDAQ:IBRX) is one of the best NASDAQ stocks under $30 to buy. On March 17, ImmunityBio announced that the National Comprehensive Cancer Network/NCCN updated its 2026 Clinical ...

Dr. Gerd examines the clinical choices involved in the management of PV, following the directives of NCCN guidelines. Aaron Gerds, MD, MS: The NCCN [National Comprehensive Cancer Network] guidelines ...

Medscape Hematology-Oncology is pleased to present the latest update to the NCCN Clinical Practice Guidelines in Oncology™ Prostate Cancer, released in December 2009. The updated NCCN Guideline, ...

FDA approved concept. Rubber stamp with FDA and medicine. 3d illustration Cancer drugs that are granted accelerated approval are less likely than drugs with regular approval to be given high-level ...